Expression of IGFBP2 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

IGFBP2 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 936.93

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

949.9

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	4564.6
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	3200.1
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	2534.1
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	2506.4
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	2482.8
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	2224.6
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	2203.4
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	2037.3
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	2007.0
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	1983.1
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	1954.5
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	1948.7
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	1941.1
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	1930.4
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	1772.2
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	1770.4
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	1746.0
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	1720.9
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	1612.7
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	1607.5
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	1578.8
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	1567.4
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	1523.9
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	1523.7
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	1510.6
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	1501.7
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	1484.6
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	1463.7
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	1447.6
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	1414.0
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	1408.9
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	1379.5
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	1359.6
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	1356.7
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	1351.7
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	1349.6
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	1328.9
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	1328.7
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	1304.3
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	1268.7
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	1238.4
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	1229.8
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	1206.0
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	1200.7
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	1143.9
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	1121.3
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	1120.9
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	1112.8
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	1100.8
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	1088.0
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	1063.2
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	1058.4
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	1036.1
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	1005.0
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	1003.4
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	984.1
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	967.9
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	956.8
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	936.9
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	917.5
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	909.3
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	888.3
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	885.5
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	868.6
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	863.5
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	860.7
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	843.4
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	836.0
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	835.6
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	796.6
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	796.2
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	784.5
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	776.4
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	774.3
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	755.6
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	752.9
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	741.0
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	739.6
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	739.3
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	733.9
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	716.3
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	715.1
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	696.1
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	692.7
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	689.7
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	678.9
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	673.5
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	669.7
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	649.5
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	648.2
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	629.8
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	616.5
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	598.6
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	574.0
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	563.7
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	560.1
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	556.3
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	552.2
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	546.8
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	537.4
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	536.2
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	525.3
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	516.9
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	479.5
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	479.2
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	455.0
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	449.4
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	449.0
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	447.2
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	444.6
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	421.5
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	418.8
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	413.1
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	404.7
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	382.7
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	358.3
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	339.0
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	309.0
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	300.7
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	285.6
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	285.5
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	276.7
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	267.4
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	248.2
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	243.0
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	217.2
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	214.9
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	198.3
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	133.4
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	126.0
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	122.8
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	113.6
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	112.2
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	106.2
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	87.9
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	82.2
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	64.0
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	58.2
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	50.7
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	39.7
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	37.7
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

IGFBP2 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 48.59

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

189.6

Number of samples

Samples

Sample	Description	pTPM
AK098	N, NA, stage:NA, dead, 660 days	938.2
AK153	N, NA, stage:NA, dead, 240 days	846.7
AK178	N, NA, stage:NA, dead, 240 days	557.9
AK072	N, NA, stage:NA, dead, 150 days	540.1
AK205	N, NA, stage:NA, dead, 120 days	430.4
AK089	N, NA, stage:NA, dead, 330 days	420.2
AK068	N, NA, stage:NA, alive, 360 days	363.1
AK142	N, NA, stage:NA, alive, 90 days	359.8
AK053	N, NA, stage:NA, dead, 300 days	359.2
AK074	N, NA, stage:NA, alive, 300 days	353.6
AK002	N, NA, stage:NA, dead, 570 days	292.0
AK139	N, NA, stage:NA, dead, 270 days	267.2
AK100	N, NA, stage:NA, alive, 960 days	262.8
AK185	N, NA, stage:NA, alive, 330 days	257.9
AK188	N, NA, stage:NA, alive, 420 days	250.6
AK043	N, NA, stage:NA, alive, 660 days	249.3
AK051	N, NA, stage:NA, dead, 360 days	243.9
AK088	N, NA, stage:NA, dead, 360 days	242.8
AK183	N, NA, stage:NA, alive, 360 days	224.0
AK071	N, NA, stage:NA, dead, 540 days	197.5
AK076	N, NA, stage:NA, alive, 660 days	192.9
AK218	N, NA, stage:NA, dead, 180 days	186.4
AK134	N, NA, stage:NA, dead, 360 days	182.4
AK236	N, NA, stage:NA, dead, 360 days	175.8
AK226	N, NA, stage:NA, dead, 360 days	170.8
AK035	N, NA, stage:NA, dead, 210 days	161.2
AK091	N, NA, stage:NA, dead, 210 days	151.3
AK123	N, NA, stage:NA, dead, 180 days	143.8
AK227	N, NA, stage:NA, alive, 300 days	142.6
AK195	N, NA, stage:NA, dead, 390 days	141.8
AK165	N, NA, stage:NA, alive, 360 days	132.4
AK049	N, NA, stage:NA, dead, 180 days	122.5
AK055	N, NA, stage:NA, dead, 240 days	118.2
AK156	N, NA, stage:NA, dead, 330 days	116.5
AK081	N, NA, stage:NA, dead, 180 days	110.4
AK173	N, NA, stage:NA, dead, 180 days	107.6
AK133	N, NA, stage:NA, dead, 360 days	102.8
AK149	N, NA, stage:NA, dead, 420 days	100.0
AK213	N, NA, stage:NA, alive, 2010 days	91.3
AK158	N, NA, stage:NA, dead, 360 days	86.4
AK199	N, NA, stage:NA, alive, 1860 days	80.3
AK099	N, NA, stage:NA, dead, 420 days	79.5
AK117	N, NA, stage:NA, dead, 210 days	60.1
AK030	N, NA, stage:NA, dead, 120 days	55.9
AK079	N, NA, stage:NA, dead, 210 days	53.6
AK231	N, NA, stage:NA, dead, 240 days	53.3
AK005	N, NA, stage:NA, dead, 240 days	43.8
AK167	N, NA, stage:NA, dead, 180 days	43.2
AK003	N, NA, stage:NA, dead, 600 days	35.9
AK216	N, NA, stage:NA, dead, 360 days	27.1
AK085	N, NA, stage:NA, alive, 660 days	26.3
AK103	N, NA, stage:NA, alive, 1320 days	17.2
AK102	N, NA, stage:NA, alive, 1740 days	7.9
AK124	N, NA, stage:NA, alive, 1920 days	6.1
AK041	N, NA, stage:NA, alive, 810 days	6.0
AK006	N, NA, stage:NA, dead, 360 days	6.0
AK015	N, NA, stage:NA, alive, 720 days	2.2
AK066	N, NA, stage:NA, alive, 960 days	2.1
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0217060003	Tumor	1.3
CPT0079790003	Tumor	1.3
CPT0217100003	Tumor	1.2
CPT0205670004	Tumor	1.2
CPT0190360004	Tumor	1.1
CPT0087680003	Tumor	1.1
CPT0093360003	Tumor	1.1
CPT0205780003	Tumor	1.1
CPT0217880003	Tumor	1.0
CPT0093510003	Tumor	1.0
CPT0123530003	Tumor	1.0
CPT0087950003	Tumor	1.0
CPT0078580003	Tumor	0.9
CPT0205570003	Tumor	0.9
CPT0162100003	Tumor	0.9
CPT0205450004	Tumor	0.8
CPT0224390004	Tumor	0.8
CPT0206880003	Tumor	0.8
CPT0161730003	Tumor	0.6
CPT0189460003	Tumor	0.6
CPT0162020003	Tumor	0.6
CPT0168380003	Tumor	0.6
CPT0125220003	Tumor	0.5
CPT0217000004	Tumor	0.5
CPT0089150003	Tumor	0.5
CPT0196850003	Tumor	0.5
CPT0092440003	Tumor	0.5
CPT0167860004	Tumor	0.4
CPT0168080003	Tumor	0.4
CPT0093590003	Tumor	0.4
CPT0175060003	Tumor	0.4
CPT0167640003	Tumor	0.3
CPT0168590003	Tumor	0.3
CPT0168830003	Tumor	0.3
CPT0218960004	Tumor	0.2
CPT0225760003	Tumor	0.2
CPT0224600003	Tumor	0.1
CPT0205890003	Tumor	0.1
CPT0127480003	Tumor	0.1
CPT0182500003	Tumor	0.0
CPT0206000004	Tumor	0.0
CPT0228220003	Tumor	-0.1
CPT0218690004	Tumor	-0.1
CPT0217430008	Tumor	-0.1
CPT0002410011	Tumor	-0.2
CPT0064650003	Tumor	-0.2
CPT0224540004	Tumor	-0.2
CPT0207090003	Tumor	-0.2
CPT0162140003	Tumor	-0.2
CPT0182580003	Tumor	-0.2
CPT0093450003	Tumor	-0.3
CPT0206110003	Tumor	-0.3
CPT0171580008	Tumor	-0.3
CPT0206450003	Tumor	-0.3
CPT0087570003	Tumor	-0.3
CPT0104330003	Tumor	-0.3
CPT0127420003	Tumor	-0.4
CPT0206230003	Tumor	-0.4
CPT0218830004	Tumor	-0.4
CPT0168720003	Tumor	-0.4
CPT0218330004	Tumor	-0.4
CPT0219080004	Tumor	-0.4
CPT0217710008	Tumor	-0.5
CPT0189650004	Tumor	-0.5
CPT0167970003	Tumor	-0.5
CPT0064890003	Tumor	-0.5
CPT0168270003	Tumor	-0.5
CPT0217190003	Tumor	-0.5
CPT0167750004	Tumor	-0.5
CPT0216920008	Tumor	-0.5
CPT0104220003	Tumor	-0.5
CPT0189570004	Tumor	-0.5
CPT0206560003	Tumor	-0.5
CPT0218890004	Tumor	-0.6
CPT0189750004	Tumor	-0.6
CPT0209440003	Tumor	-0.6
CPT0206780003	Tumor	-0.6
CPT0206330003	Tumor	-0.6
CPT0189250003	Tumor	-0.6
CPT0206670004	Tumor	-0.7
CPT0221180003	Tumor	-0.7
CPT0218770003	Tumor	-0.7
CPT0093550003	Tumor	-0.7
CPT0167530003	Tumor	-0.7
CPT0189850004	Tumor	-0.7
CPT0087730003	Tumor	-0.9
CPT0225730003	Tumor	-0.9
CPT0207030003	Tumor	-1.0
CPT0204370003	Normal	-1.0
CPT0071100003	Tumor	-1.0
CPT0199770003	Tumor	-1.0
CPT0204360003	Normal	-1.1
CPT0204340003	Normal	-1.2
CPT0204330003	Normal	-1.2
CPT0208980003	Tumor	-1.2
CPT0204380003	Normal	-1.2
CPT0204400003	Normal	-1.3
CPT0125510003	Tumor	-1.3
CPT0186100003	Tumor	-1.3
CPT0204390003	Normal	-1.4
CPT0204410003	Normal	-1.4
CPT0204350003	Normal	-1.4
CPT0224330003	Tumor	-1.5
CPT0125570003	Tumor	-1.5
CPT0182550003	Tumor	-1.6
CPT0168480003	Tumor	-1.6
CPT0218670003	Tumor	-1.6
CPT0201710003	Tumor	-1.6
CPT0204420003	Normal	-1.9
CPT0190240004	Tumor	-2.2
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis